Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-08-03

EMA Authorised: Clopidogrel Zentiva (previously Clopidogrel Winthrop) (clopidogrel) — Zentiva k.s.

View source ↗

Summary

Authorisation granted for Clopidogrel Zentiva (clopidogrel), expanding or confirming its availability for stroke, peripheral vascular diseases, acute coronary s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clopidogrel Zentiva (clopidogrel)

Snippet

Status: Authorised. Therapeutic area: Stroke;Peripheral Vascular Diseases;Myocardial Infarction;Acute Coronary Syndrome. MAH: Zentiva k.s.. Decision date: 27/07/2026